Literature DB >> 26382148

Determination of Fatty Acid Oxidation and Lipogenesis in Mouse Primary Hepatocytes.

Thomas E Akie1, Marcus P Cooper2.   

Abstract

Lipid metabolism in liver is complex. In addition to importing and exporting lipid via lipoproteins, hepatocytes can oxidize lipid via fatty acid oxidation, or alternatively, synthesize new lipid via de novo lipogenesis. The net sum of these pathways is dictated by a number of factors, which in certain disease states leads to fatty liver disease. Excess hepatic lipid accumulation is associated with whole body insulin resistance and coronary heart disease. Tools to study lipid metabolism in hepatocytes are useful to understand the role of hepatic lipid metabolism in certain metabolic disorders. In the liver, hepatocytes regulate the breakdown and synthesis of fatty acids via β-fatty oxidation and de novo lipogenesis, respectively. Quantifying metabolism in these pathways provides insight into hepatic lipid handling. Unlike in vitro quantification, using primary hepatocytes, making measurements in vivo is technically challenging and resource intensive. Hence, quantifying β-fatty acid oxidation and de novo lipogenesis in cultured mouse hepatocytes provides a straight forward method to assess hepatocyte lipid handling. Here we describe a method for the isolation of primary mouse hepatocytes, and we demonstrate quantification of β-fatty acid oxidation and de novo lipogenesis, using radiolabeled substrates.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26382148      PMCID: PMC4692567          DOI: 10.3791/52982

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  11 in total

Review 1.  Nonalcoholic fatty liver disease.

Authors:  Paul Angulo
Journal:  N Engl J Med       Date:  2002-04-18       Impact factor: 91.245

2.  The natural history of nonalcoholic fatty liver disease: a population-based cohort study.

Authors:  Leon A Adams; James F Lymp; Jenny St Sauver; Schuyler O Sanderson; Keith D Lindor; Ariel Feldstein; Paul Angulo
Journal:  Gastroenterology       Date:  2005-07       Impact factor: 22.682

3.  Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease.

Authors:  Kerry L Donnelly; Coleman I Smith; Sarah J Schwarzenberg; Jose Jessurun; Mark D Boldt; Elizabeth J Parks
Journal:  J Clin Invest       Date:  2005-05       Impact factor: 14.808

4.  Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease.

Authors:  Jennifer E Lambert; Maria A Ramos-Roman; Jeffrey D Browning; Elizabeth J Parks
Journal:  Gastroenterology       Date:  2013-12-04       Impact factor: 22.682

Review 5.  Thematic review series: patient-oriented research. Recent advances in liver triacylglycerol and fatty acid metabolism using stable isotope labeling techniques.

Authors:  Elizabeth J Parks; Marc K Hellerstein
Journal:  J Lipid Res       Date:  2006-06-01       Impact factor: 5.922

6.  Prevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988-1994.

Authors:  Mariana Lazo; Ruben Hernaez; Mark S Eberhardt; Susanne Bonekamp; Ihab Kamel; Eliseo Guallar; Ayman Koteish; Frederick L Brancati; Jeanne M Clark
Journal:  Am J Epidemiol       Date:  2013-05-23       Impact factor: 4.897

7.  Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis.

Authors:  Ariel E Feldstein; Ali Canbay; Paul Angulo; Makiko Taniai; Lawrence J Burgart; Keith D Lindor; Gregory J Gores
Journal:  Gastroenterology       Date:  2003-08       Impact factor: 22.682

8.  The prevalence and etiology of elevated aminotransferase levels in the United States.

Authors:  Jeanne M Clark; Frederick L Brancati; Anna Mae Diehl
Journal:  Am J Gastroenterol       Date:  2003-05       Impact factor: 10.864

9.  Direct assessment of hepatic mitochondrial oxidative and anaplerotic fluxes in humans using dynamic 13C magnetic resonance spectroscopy.

Authors:  Douglas E Befroy; Rachel J Perry; Nimit Jain; Sylvie Dufour; Gary W Cline; Jeff K Trimmer; Julia Brosnan; Douglas L Rothman; Kitt Falk Petersen; Gerald I Shulman
Journal:  Nat Med       Date:  2013-12-08       Impact factor: 53.440

10.  Improved isolation of murine hepatocytes for in vitro malaria liver stage studies.

Authors:  Lígia A Gonçalves; Ana M Vigário; Carlos Penha-Gonçalves
Journal:  Malar J       Date:  2007-12-20       Impact factor: 2.979

View more
  17 in total

1.  Effects of high-fat diet and AMP-activated protein kinase modulation on the regulation of whole-body lipid metabolism.

Authors:  Milena Schönke; Julie Massart; Juleen R Zierath
Journal:  J Lipid Res       Date:  2018-05-08       Impact factor: 5.922

2.  Glial Cell Line-Derived Neurotrophic Factor Enhances Autophagic Flux in Mouse and Rat Hepatocytes and Protects Against Palmitate Lipotoxicity.

Authors:  Simon Musyoka Mwangi; Ge Li; Lan Ye; Yunshan Liu; Francois Reichardt; Samantha M Yeligar; C Michael Hart; Mark J Czaja; Shanthi Srinivasan
Journal:  Hepatology       Date:  2019-03-22       Impact factor: 17.425

3.  Multi-dimensional Transcriptional Remodeling by Physiological Insulin In Vivo.

Authors:  Thiago M Batista; Ruben Garcia-Martin; Weikang Cai; Masahiro Konishi; Brian T O'Neill; Masaji Sakaguchi; Jong Hun Kim; Dae Young Jung; Jason K Kim; C Ronald Kahn
Journal:  Cell Rep       Date:  2019-03-19       Impact factor: 9.423

4.  Differentiation and Metabolic Interrogation of Human Adipocytes.

Authors:  Nicki A Baker; Lindsey A Muir; Carey N Lumeng; Robert W O'Rourke
Journal:  Methods Mol Biol       Date:  2017

5.  Regulation of UCP1 and Mitochondrial Metabolism in Brown Adipose Tissue by Reversible Succinylation.

Authors:  GuoXiao Wang; Jesse G Meyer; Weikang Cai; Samir Softic; Mengyao Ella Li; Eric Verdin; Christopher Newgard; Birgit Schilling; C Ronald Kahn
Journal:  Mol Cell       Date:  2019-04-15       Impact factor: 17.970

6.  Adaptation of Oxidative Phosphorylation Machinery Compensates for Hepatic Lipotoxicity in Early Stages of MAFLD.

Authors:  Pia Fahlbusch; Aleksandra Nikolic; Sonja Hartwig; Sylvia Jacob; Ulrike Kettel; Cornelia Köllmer; Hadi Al-Hasani; Stefan Lehr; Dirk Müller-Wieland; Birgit Knebel; Jörg Kotzka
Journal:  Int J Mol Sci       Date:  2022-06-20       Impact factor: 6.208

7.  Calcium/calmodulin-dependent protein kinase kinase 2 regulates hepatic fuel metabolism.

Authors:  Brittany A Stork; Adam Dean; Andrea R Ortiz; Pradip Saha; Nagireddy Putluri; Maricarmen D Planas-Silva; Iqbal Mahmud; Kimal Rajapakshe; Cristian Coarfa; Stefan Knapp; Philip L Lorenzi; Bruce E Kemp; Benjamin E Turk; John W Scott; Anthony R Means; Brian York
Journal:  Mol Metab       Date:  2022-05-11       Impact factor: 8.568

8.  The novel adipokine WISP1 associates with insulin resistance and impairs insulin action in human myotubes and mouse hepatocytes.

Authors:  Tina Hörbelt; Christopher Tacke; Mariya Markova; Daniella Herzfeld de Wiza; Frederique Van de Velde; Marlies Bekaert; Yves Van Nieuwenhove; Silke Hornemann; Maria Rödiger; Nicole Seebeck; Elisabeth Friedl; Wenke Jonas; G Hege Thoresen; Oliver Kuss; Anke Rosenthal; Volker Lange; Andreas F H Pfeiffer; Annette Schürmann; Bruno Lapauw; Natalia Rudovich; Olga Pivovarova; D Margriet Ouwens
Journal:  Diabetologia       Date:  2018-05-12       Impact factor: 10.122

9.  Simultaneous tracers and a unified model of positional and mass isotopomers for quantification of metabolic flux in liver.

Authors:  Stanislaw Deja; Xiaorong Fu; Justin A Fletcher; Blanka Kucejova; Jeffrey D Browning; Jamey D Young; Shawn C Burgess
Journal:  Metab Eng       Date:  2019-12-28       Impact factor: 9.783

10.  Ellagic Acid and Its Microbial Metabolite Urolithin A Alleviate Diet-Induced Insulin Resistance in Mice.

Authors:  Jieping Yang; Yuanqiang Guo; Susanne M Henning; Brenda Chan; Jianfeng Long; Jin Zhong; Rebeca Acin-Perez; Anton Petcherski; Orian Shirihai; David Heber; Zhaoping Li
Journal:  Mol Nutr Food Res       Date:  2020-08-23       Impact factor: 6.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.